Articles tagged with: Michael Carter

HIV-positive transgender men in US have significant unmet medical and social needs

published: December, 11, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Research, Health, Revolving Door, International , Treatment, Guest Authors, Living with HIV, Media

“Although these transgender men had access to HIV medical care, many experienced poor health outcomes and unmet needs,” write the authors. From AIDSmap, Michael Carter reports.

HIV-positive transgender men in US have significant unmet medical and social needs

HIV-positive transgender men in the United States have significant unmet social and healthcare needs, according to a study published in Research and Practice. Approximately half were living in poverty and only 60% had sustained viral suppression. “Many transgender men receiving HIV medical care in the United States face socioeconomic challenges and suboptimal health outcomes,” write the authors. “Although these transgender men had access to HIV medical care, many experienced poor hea

Starting ART immediately after HIV diagnosis cuts mortality risk by two-thirds for people with high CD4 cell counts

published: November, 08, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , General Health, Treatment Guidelines -including when to start, Health, Revolving Door, International , Treatment, Guest Authors, Media

Over 12 months of follow-up, individuals who started antiretrovirals within 30 days of their diagnosis had a 63% reduction in their mortality risk compared to people who remained antiretroviral-naïve. From AIDSmap, Michael Carrter reports.

Starting ART immediately after HIV diagnosis cuts mortality risk by two-thirds for people with high CD4 cell counts

People with a high CD4 cell count who start antiretroviral therapy (ART) immediately after diagnosis with HIV cut their 12-month mortality risk by two-thirds, according to research conducted in China and published in Clinical Infectious Diseases. The retrospective study involved over 35,000 people who were newly diagnosed with HIV between 2012 and 2014. All had a CD4 cell count above 500 cells/mm3. Over 12 months of follow-up, individuals who started antiretrovirals within 30 days of their d

Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

published: November, 01, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Health, Revolving Door, Guest Authors, Media

"... we found that elevated coffee consumption had an independent protective effect on all-cause mortality risk.” From Infohep.org, Michael Carter reports.

Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection, French investigators report in the Journal of Hepatology. The protective effect of coffee consumption observed in the study was much larger than the 14% reduction in mortality observed in the general population. “In this large prospective nationwide cohort of patients co-infected with HIV-HCV followed-up in French hospital departments, we found t

Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

published: October, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Treatment Guidelines -including when to start, Research, Sexual Health, Health, Revolving Door, International , Treatment, Guest Authors, Media

"It removes the requirement to take daily treatment and the need to maintain high levels of treatment adherence." From AIDSmap, Michael Carter reports.

Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

Approximately a third of gay and bisexual men who are currently taking oral (tenofovir/emtricitabine) pre-exposure prophylaxis (PrEP) would prefer long-acting injectable PrEP should it become available, investigators report in AIDS and Behavior. Individuals were less likely to prefer injectable PrEP if they had concerns about the level of protection it provided against HIV and/or about its durability. “About one-third of GBM [gay and bisexual men] currently taking oral PrEP would prefer LA

Depression highly prevalent among people living with HIV in sub-Saharan Africa

published: October, 02, 2017 Written by // Guest Authors - Revolving Door

Globally, the mental health of HIV-positive individuals is an increasing concern. From AIDSmap, Michael Carter reports.

Depression highly prevalent among people living with HIV in sub-Saharan Africa

Depression is very common among people living with HIV in sub-Saharan Africa, according to the results of a systematic review and meta-analysis published in PLOS One. Prevalence ranged between 9 and 32%, but differed between screening tools and also according to antiretroviral therapy (ART) status. Risk factors for depression included economic hardship, female sex and immunosuppression, but there was little consistency between studies. “This analysis of the available most recent literature

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

published: August, 17, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Research, Health, International , Revolving Door, Guest Authors, Media

From AIDSmap, Michael Carter reports on the first study to predict the incidence of anal cancer in HIV-positive MSM long term, taking into account cART [combination antiretroviral therapy] coverage and individual CD4 cell trajectories.

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

The incidence of anal cancer among HIV-positive gay men peaked in 2009 and will decline substantially by 2030, even with current levels of antiretroviral therapy (ART) coverage and no cancer-screening programme, Swiss investigators report in AIDS. Further significant reductions would be achieved with 100% treatment coverage and various screening strategies. These would be more effective at preventing cases of anal populationcancer than screening for cervical cancer among women in the gener

Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

published: July, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Health, Revolving Door, International , Treatment, Guest Authors, Media

“Low-level viral loads between 400 and 999 copies/ml shortly after starting ART appear to place patients at a significantly higher 10-year risk of death than patients with viral loads under 20 copies/ml..." From AIDSmap, Michael Carter reports.

Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the United States report in the online edition of AIDS. People with a viral load between 400 and 999 copies/ml had a 20% mortality risk, similar to the 23% risk observed in people with a viral load between 1000 and 4 million copies/ml. In contrast, the mortality risk was only 14% for individuals who rapidly achieved complete viral suppressio

Researchers say rule out depression, anxiety, unemployment and other stresses before blaming cognitive impairment for everyday difficulties

published: June, 29, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Mental Health, Revolving Door, International , Guest Authors, Media

"Failure to recognise these important elements of patients’ lived experiences risks diagnostic delay, failure to address important needs, unnecessary investigations and further anxiety.” From AIDSmap. Michael Carter reports on the CIPHER Study.

Researchers say rule out depression, anxiety, unemployment and other stresses before blaming cognitive impairment for everyday difficulties

One in five people living with HIV in a European study reported a decline in everyday functioning as a result of cognitive problems such as memory loss, difficulties in solving problems, poor concentration or reduced attention span, researchers from the CIPHER study group report in the Journal of Acquired Immune Deficiency Syndromes. But, researchers say, people who reported these problems were also more likely to have comorbid conditions, to be depressed or anxious, to be unemployed and e

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

published: June, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , General Health, Treatment Guidelines -including when to start, Research, Health, Revolving Door, International , Treatment, Guest Authors, Media

From AIDSmap, Michael Carter reports on a study that demonstrated the feasibility of using commitment contracts in HIV care.

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

People who enter into a contract with their HIV healthcare provider to receive cash incentives in return for high levels of antiretroviral therapy (ART) adherence are more likely to achieve sustained viral suppression compared to people in a control arm, investigators from the United States report in the online edition of AIDS. The study recruited individuals with ongoing viral replication despite at least six months of ART. Individuals who entered into a commitment contract were appro

People with HIV have impaired respiratory health, even when viral load is undetectable

published: June, 08, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Health, Revolving Door, International , Smoking Cessation , Guest Authors, Living with HIV, Media, Opinion Pieces

From AIDSmap, Michael Carter reports on a study that explores the relationship between HIV infection and respiratory health in the modern ART era.

People with HIV have impaired respiratory health, even when viral load is undetectable

HIV-positive people have impaired respiratory health, even when they have viral suppression with antiretroviral therapy (ART), investigators from London report in HIV Medicine. Respiratory health was compared between HIV-positive and HIV-negative outpatients. Individuals with HIV had poorer respiratory health and were more likely to report breathlessness than HIV-negative participants, findings which remained unchanged when analysis focused on ART-treated HIV-positive people with an undetec

[12  >>